Talledo, Nenita F.
HRN: 08-53-62 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/01/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
07/01/2023
07/21/2023
IVTT
600
Q8
Infected Wound, T/ C Necrotizing Fasciitis
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes